Viewing Study NCT07214259


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-03 @ 6:21 AM
Study NCT ID: NCT07214259
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intervention for Alcohol Use Disorder Recovery After Liver Transplantation
Sponsor: Leigh Anne Dageforde
Organization:

Study Overview

Official Title: Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery After Liver Transplantation
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ILTARP
Brief Summary: The goal of this clinical trial is to learn if it is feasible and acceptable to use a recovery coach and an online sober active community to help with alcohol use disorder after liver transplant. The main questions it aims to answer are:

* Is using a recovery coach after liver transplant to help with alcohol use recovery feasible and acceptable?
* Is using an online sober active community after liver transplant to help with alcohol use recovery feasible and acceptable? Researchers will compare standard of care including a recovery coach alone to a recovery coach plus to assist with recovery from alcohol use recovery after liver transplant

Participants will:

* Work with a recovery coach including a weekly phone call
* Visit the clinic once every 3 months for a checkup and to complete surveys
* If randomized to the intervention arm, download an online application with access to a digital sober active community
Detailed Description: Rates of alcohol use disorder and alcohol associated liver disease requiring liver transplantation continue to rapidly rise. Return to alcohol use after liver transplant is associated with increased rates of liver transplant failure and mortality, but there is no evidence-based integrated intervention to address alcohol use disorder in liver transplant recipients. The goal of this pilot feasibility randomized control trial is to address a critical gap in knowledge and care for liver transplant recipients with concurrent alcohol use disorder by developing and pilot testing an integrated liver transplant and alcohol recovery program (ILTARP) consisting of a recovery coach supporting post-transplant alcohol relapse prevention, outreach, and care coordination with the added intervention of access to an active sober community. The investigators will conduct a pilot feasibility study of the newly developed ILTARP intervention testing feasibility, acceptability, and potential effectiveness of ILTARP in the liver transplant clinical setting.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
K23AA031068 NIH None https://reporter.nih.gov/quic… View